Effect of Nafamostat on Postreperfusion Syndrome (PRS)
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This study intends to see the effect of nafamostat on the attenuation of postreperfusion
syndrome (PRS) that frequently occurs during liver transplantation.